These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5590823)

  • 1. [Bacteriologic surveillance of the sputum of 22 patients with mucoviscidosis].
    Feigelson J; Pecau Y
    Arch Fr Pediatr; 1967 Dec; 24(10):1135-47. PubMed ID: 5590823
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriological studies of bronchial secretions in 19 cases of cystic fibrosis.
    Feigelson J; Pecau Y
    Bibl Paediatr; 1967; 86():214-26. PubMed ID: 4964164
    [No Abstract]   [Full Text] [Related]  

  • 3. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
    Hawley HB; Lewis RM; Swartz DR; Gump DW
    Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
    [No Abstract]   [Full Text] [Related]  

  • 4. L forms in patients with cystic fibrosis.
    Bruns WT; Brown BA
    Am Rev Respir Dis; 1970 Jun; 101(6):935-40. PubMed ID: 4986861
    [No Abstract]   [Full Text] [Related]  

  • 5. [Statistical findings on flora isolated from sputum of mucoviscidosis patients].
    Mengoli V; Bonomi U; Mastella G; Piacentini I; Barbato GP; Girelli-Bruni E; Bellini P
    Fracastoro; 1970; 63(3):549-61. PubMed ID: 5517028
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
    Bauernfeind A; Przyklenk B
    Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunoglobulins in the serum, sputum and saliva in patients affected with cystic fibrosis (mucoviscidosis) and important respiratory complications].
    Marcer V; Mastella G; Mengoli V
    Riv Clin Pediatr; 1970; 83(3):135-43. PubMed ID: 5525622
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol.
    Macfarlane M; Leavy A; McCaughan J; Fair R; Reid AJ
    J Hosp Infect; 2007 Mar; 65(3):231-6. PubMed ID: 17178427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problems of antibiotic therapy in mucoviscidosis].
    Steinitz H
    Z Allgemeinmed; 1972 Aug; 48(24):1085-9. PubMed ID: 4649651
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro effect of antibiotics on microorganisms in the sputum from mucoviscidosis patients evaluated by the standard antibiogram].
    Bonomi U; Mastella G; Piacentini I; Barbato G; Bellini P; Girelli-Bruni E
    Fracastoro; 1970; 63(3):562-78. PubMed ID: 5517029
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacterial infection in cystic fibrosis.
    May JR; Herrick NC; Thompson D
    Arch Dis Child; 1972 Dec; 47(256):908-13. PubMed ID: 4630478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
    Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ
    J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Slime from a mucoid strain of Pseudomonas aeruginosa in mucoviscidosis and other respiratory diseases (author's transl)].
    Marty N; Lapchine L; Pradere J; Dutau G
    Ann Pediatr (Paris); 1981 Apr; 28(4):261-5. PubMed ID: 6784657
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antimicrobial susceptibility of bacterial isolates from patients with cystic fibrosis].
    García AD; Ibarra A; Rodríguez FC; Casal M
    Rev Esp Quimioter; 2004 Dec; 17(4):332-5. PubMed ID: 15696223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High phenotypic diversity in infecting but not in colonizing Staphylococcus aureus populations.
    Goerke C; Gressinger M; Endler K; Breitkopf C; Wardecki K; Stern M; Wolz C; Kahl BC
    Environ Microbiol; 2007 Dec; 9(12):3134-42. PubMed ID: 17991040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.